The present study found beneficial effects of mirodenafil, a PDE5 inhibitor, in measures of sensorimotor, cognitive, and histopathological recovery following stroke in both tMCAO and pMCAO models of stroke in rats. This evidence concerns the gene PDE5A and stroke disorder.